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Background: Lower risk of COPD has been reported in black and Asian people, raising ques-
tions of poorer recognition or reduced susceptibility. We assessed prevalence and severity of 
COPD in ethnic groups, controlling for smoking.
Method: A retrospective cross-sectional study using routinely collected primary care data in 
London. COPD prevalence, severity (% predicted forced expiratory volume in 1 second [FEV
1
]), 
smoking status, and treatment were compared between ethnic groups, adjusting for age, sex, 
smoking, deprivation, and practice clustering.
Results: Among 358,614 patients in 47 general practices, 47.6% were white, 20% black, and 
5% Asian. Prevalence of COPD was 1.01% overall, 1.55% in whites, 0.58% in blacks, and 
0.78% in Asians. COPD was less likely in blacks (adjusted odds ratio [OR], 0.44; 95% con-
fidence interval [CI] 0.39–0.51) and Asians (0.82; CI, 0.68–0.98) than whites. Black COPD 
patients were less likely to be current smokers (OR, 0.56; CI, 0.44–0.71) and more likely to be 
never-smokers (OR, 4.9; CI, 3.4–7.1). Treatment of patients with similar disease severity was 
similar irrespective of ethnic origin, except that long-acting muscarinic antagonists were pre-
scribed less in black COPD patients (OR, 0.53; CI, 0.42–0.68). Black ethnicity was a predictor 
of poorer lung function (% predicted FEV
1
: B coefficient, -7.6; P,0.0001), an effect not seen 
when ethnic-specific predicted FEV
1
 values were used.
Conclusion: Black people in London were half as likely as whites to have COPD after 
adjusting for lower smoking rates in blacks. It seems likely that the differences observed were 
due either to ethnic differences in the way cigarettes were smoked or to ethnic differences in 
susceptibility to COPD.
Keywords: COPD, smoking, ethnicity
Introduction
In the only population study to assess COPD prevalence by ethnicity to date, Martin et al1 
found a lower prevalence of COPD among black and Asian people compared to white 
people, although there were relatively small numbers of black people in their study. 
Black and Asian COPD patients reported less severe breathlessness than white patients, 
although their severity according to % predicted forced expiratory volume in 1 second 
(FEV
1
) was not significantly different. White et al2 found that 8.5% of patients diagnosed 
with COPD in a South London population were black, compared to 25.8% of the local 
population overall, although ethnicity data were only available on 54.8% of the study 
population. The apparent lower prevalence of COPD in black people raises the ques-
tion whether this is due to poorer detection or lower risk of disease.
Nacul et al3 predicted that the highest prevalence of COPD would be among black 
men in deprived areas, using the relatively small numbers of data from the Health Survey 
for England. Mortality from COPD appears higher in blacks in the USA.4 Eisner et al5 
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found more severe disease in black COPD patients, but this 
effect disappeared when accounting for household income and 
educational attainment. Han et al6 found increased hospital 
admissions and adverse effects on quality of life because of 
COPD among black patients compared to white patients. Can-
non et al7 found that black patients with COPD exacerbation 
were more likely to receive mechanical ventilation in hospital. 
Mowls et al8 found that blacks with COPD were more likely 
to have had spirometry performed. A US cross-sectional 
study found that black ethnicity did not affect the relationship 
between cigarette exposure and deterioration in lung function, 
but it did not examine clinical COPD diagnosis.9
COPD is an important health burden.10 It accounts for 
over 25,000 deaths in the UK11 and is the second biggest 
cause of emergency hospital admissions.12,13 The main risk 
factor for COPD in the UK is cigarette smoking.10
Spirometry, upon which the diagnosis and severity clas-
sification of COPD depends, differs in healthy individuals 
between ethnic groups. US studies have suggested that pre-
dicted FEV
1
 and predicted forced vital capacity (FVC) based 
on height may be overestimated by 12% in black subjects.14,15 
A London study demonstrated that white people have higher 
mean FVC than black and Asian people when controlling 
for height and sex, but there was no difference in FEV
1
/FVC 
ratio (implying that FEV
1
 was also lower in black and Asian 
people).16 Lower FVC in black people is associated with 
higher mortality than in white people when controlling for 
FEV
1
/FVC ratio, age, height, and sex.17 This led Burney and 
Hooper17 to suggest that “normal” spirometry values should be 
the same for different ethnic groups for prognostic purposes, 
to take into account higher mortality associated with lower 
FVC. An adjustment for ethnicity is currently recommended 
in the UK by the British Thoracic Society (BTS) and the 
Association for Respiratory Technology and Physiology,18 
but it is unclear how widely this is actually performed.
The observation of differences between ethnic groups in the 
prevalence of COPD and in the predicted values of spirometry 
demands closer examination. A better appreciation of ethnic 
differences in disease susceptibility and disease burden will 
enable us to target health inequalities and improve our under-
standing of disease pathogenesis and treatment.19 In this study, 
we have examined ethnic differences at a population level in 
the prevalence, severity, and treatment of COPD in London.
Method
study design
This retrospective cross-sectional study used routinely col-
lected primary care data to assess the prevalence of COPD 
and its patient and practice predictors. Lambeth DataNet, an 
anonymized primary care database, has data from all electronic 
patient records from 47 out of 48 general practices in the 
London Borough of Lambeth. Data were collected with the 
approval of Lambeth Information Governance Committee 
(October 2013). The data, anonymized prior to being received 
for this analysis, was defined by the South London Primary 
Care Research Governance Team, St George’s Hospital Medi-
cal School, London, as audit style and therefore not requiring 
research governance or ethical approval.
sample
All patients of all ages registered with 47 participating 
general practices in Lambeth on October 31, 2013 were 
eligible. Data were extracted on October 31, 2013. Data 
had been collected over 30 preceding years, but mostly in 
the preceding 3 years. Where there were multiple values 
for a variable, the most recent value was used. All patients 
with a current diagnosis of COPD, (including emphysema, 
chronic bronchitis, and other International Classification of 
Diseases, Revision 10 diagnostic codes J41-J44.9 consistent 
with COPD) were used to calculate prevalence of COPD. 
A subgroup of spirometry-confirmed COPD was identified: 
those with a recorded diagnosis of COPD and Global Initia-
tive for Chronic Obstructive Lung Disease (GOLD)-defined 
obstructive spirometry (ratio of FEV
1
/FVC ,0.7).20
Measures
COPD severity was defined by % predicted FEV
1
. When % 
predicted FEV
1
 was not recorded but FEV
1
, age, and height 
were available, we calculated % predicted FEV
1
 using the 
European Coal and Steel Community (ECSC) reference 
equations,21 as recommended by BTS.18
Binary variables (yes/no) were created for each class of 
COPD medication, which were positive if they had been pre-
scribed in the preceding year. Strength, dosage, and volume 
of prescribed medications were not recorded. Medications 
were categorized as: short-acting β agonists (SABA), 
short-acting muscarinic antagonists (SAMA), long-acting 
β agonists (LABA), long-acting muscarinic antagonists 
(LAMA), inhaled corticosteroids (ICS), ICS/LABA combi-
nations, oral steroids, theophyllines, and mucolytics.
Self-reported ethnicity was recorded by practices accord-
ing to the UK 2001 Census ethnic group (and subgroup) 
categories: white (white British/mixed; Irish white; Other 
white); mixed (white and black Caribbean; white and black 
African; white and Asian; mixed other); Asian or Asian 
British (Indian/British Indian; Pakistani/British Pakistani; 
Bangladeshi; other Asian); black or black British (Caribbean; 
African; other black); Chinese/other (Chinese; other ethnic 
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group); unknown; and not stated.22 The Asian category in 
the UK census ethnicity categories refers to people of south 
Asian background (Indian, Pakistani, and Bangladeshi 
nationalities). This is different from the census categories 
in other societies, which may include those of south-east 
Asian and Far East origin (including Japan and the People’s 
Republic of China) in the category Asian.23
The most recently entered smoking code was used to label 
each patient as a current smoker, ex-smoker, or never smoker. 
Where there were conflicting smoking codes in the same 
patient, the most appropriate code was applied (eg, patients 
with recent “never smoked tobacco” and previous “smoker” 
were recoded as “ex-smoker”).
An Index of Multiple Deprivation (IMD-10) score for 
social deprivation was assigned at patient level and mapped to 
lower super output area using postcode. IMD score is based on 
national census and local authority data, and reflects depriva-
tion specific to geographical areas.24 IMD scores in 2010 ranged 
nationally from 0 (least deprived) to 88 (most deprived).
statistical analysis
Raw prevalence of COPD was calculated for the whole 
population and for each ethnic group. Likelihood of COPD 
diagnosis was compared between ethnic groups using mul-
tiple logistic regression, adjusting for age, sex, smoking, 
IMD score, and practice clustering. Among COPD patients, 
the following were compared between ethnic groups: treat-
ment with each class of medication using multiple logistic 
regression; % predicted FEV
1
 (as a marker of severity) using 
multiple linear regression; and likelihood of being a current 
smoker or a never-smoker using multiple logistic regression. 
Patients with ethnicity unknown or not stated were excluded 
from regression analyses, because these were not felt to be 
valid descriptors of ethnicity.
Stata software version 13 (StataCorp LP, College Station, 
TX, USA) was used for all statistical analysis.
sensitivity analyses
The main COPD analysis was repeated using confirmed 
COPD as the dependent variable to see if excluding those 
with a COPD diagnosis without spirometry confirmation 
affected the relationship between ethnicity and risk of 
COPD.
The linear regression analysis for COPD severity was 
repeated after adjusting for ethnicity by reducing predicted 
FEV
1
 by 13% for black patients and 7% for Asian patients, 
as recommended by the BTS18 and consistent with several 
US studies.14,15,25
Results
Participants
Data were collected on 358,614 patients across 47 practices. 
Overall population characteristics are shown in Table 1, with 
the characteristics of COPD patients in Table 2. Ethnicity 
data were recorded for 81.3% of all patients and 91.7% of 
COPD patients. Smoking status was recorded for 82% of all 
patients and 99.8% of COPD patients.
All minority ethnic groups, but especially black people, 
were significantly less likely than white people to have a 
diagnosis of COPD when controlling for age, sex, smoking, 
deprivation, and practice clustering (Table 3). Repeating the 
analysis with spirometry-confirmed COPD as the dependent 
variable did not significantly affect the results. The analysis 
was extended to ethnic subgroups, controlling for the same 
factors, revealing high prevalence of COPD among white 
Irish (Table 3).
smoking history
Among COPD patients, black patients were significantly less 
likely to be current smokers than white patients (OR, 0.56; 
CI, 0.44–0.71) after controlling for age, sex, IMD score, and 
practice clustering (Table 4). They were also five times more 
likely to have never smoked than white patients (adjusted 
Table 1 Characteristics of the whole population (age, sex, smoking status, IMD score, COPD diagnosis, and spirometry-confirmed 
COPD) by ethnic group
Ethnic group N (%) Mean 
age 
(years)
Male 
(%)
Current 
smoker 
(%)
Ex-smoker 
(%)
Never 
smoker 
(%)
Smoker 
status 
unknown (%)
Mean 
IMD 
score
Recorded 
COPD 
diagnosis (%)
Spirometry-
confirmed 
COPD (%)
White group 170,632 (48) 37 49 22 24 43 11 30 1.55 0.77
Black or black British 71,836 (20) 35 47 14 14 51 20 34 0.58 0.26
asian or asian British 18,770 (5) 36 53 13 13 59 15 27 0.78 0.34
Mixed 16,803 (5) 28 46 18 14 40 28 32 0.50 0.17
Chinese/other 13,650 (4) 35 47 15 16 55 15 32 0.34 0.13
Unknown 57,107 (16) 33 55 17 13 39 32 31 0.41 0.15
not stated 9,816 (3) 30 51 15 15 36 34 31 0.65 0.29
all 358,614 35 49 18 19 45 18 31 1.01 0.48
Abbreviation: IMD, index of multiple deprivation.
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Table 2 Characteristics of COPD patients (age, sex, smoking status, IMD score, and spirometry-confirmed COPD) by ethnic group
Ethnic group N (%) Mean 
age 
(years)
Male 
(%)
Current 
smoker 
(%)
Ex-smoker 
(%)
Never 
smoker 
(%)
Smoker 
status 
unknown (%)
Mean 
IMD 
score
Spirometry-
confirmed 
COPD (%)
White group 2,637 (73) 68 52 43 52 5 0.1 32 50
Black or black British 416 (11) 69 69 31 52 16 0.5 34 44
asian or asian British 146 (4) 67 75 35 46 19 0.0 31 44
Mixed 84 (2) 66 57 40 43 17 0.0 34 33
Chinese/other 47 (1) 65 70 21 51 28 0.0 30 38
Unknown 236 (7) 68 60 40 47 11 1.7 32 36
not stated 64 (2) 70 69 30 56 14 0.0 30 44
all 3,630 68 56 41 51 8 0.2 32 48
Abbreviation: IMD, index of multiple deprivation.
Table 3 Comparison of likelihood of COPD diagnosis and spirometry-confirmed COPD diagnosis between ethnic groups and 
subgroups, with white and white British as baseline
Ethnic group COPD 
diagnosis 
OR
95% 
confidence 
interval
Spirometry-
confirmed 
COPD
OR
95% 
confidence 
interval
Ethnic subgroup COPD 
diagnosis 
OR
95% 
confidence 
interval
White 1 1 White British/mixed 1
Irish white 1.35 1.13–1.62
Other white 0.55 0.46–0.67
Black or black British 0.44 0.39–0.51 0.42 0.36–0.49 Caribbean 0.45 0.38–0.52
african 0.32 0.25–0.41
Other black 0.26 0.18–0.39
asian or asian British 0.82 0.68–0.98 0.74 0.57–0.96 Indian/British Indian 0.65 0.47–0.90
Pakistani/British Pakistani 0.95 0.61–1.50
Bangladeshi 0.63 0.37–1.07
Other asian 0.76 0.60–0.97
Mixed 0.70 0.49–0.98 0.49 0.32–0.74 White and black Caribbean 0.76 0.47–1.25
White and black african 0.21 0.09–0.51
White and asian 0.61 0.28–1.36
Mixed other 0.67 0.49–0.91
Chinese/other 0.41 0.28–0.60 0.34 0.16–0.70 Chinese 0.34 0.21–0.58
Other ethnic group 0.38 0.23–0.63
Notes: Multiple logistic regression controlling for age, sex, smoking status, deprivation, and practice clustering. excludes people with no recording of ethnicity (n=247,939). 
Bold indicates significance, P,0.05.
Abbreviation: Or, odds ratio.
Table 4 Comparison of smoking history in COPD patients between ethnic groups (n=3,330)
Ethnic group Frequency % currently  
smoking
OR for currently  
smoking
95% CI % never  
smoked
OR for never  
smoked
95% CI
White 2,637 43.2 1 4.8 1
Black 416 31.5 0.56 0.44–0.71 15.6 4.9 3.4–7.1
asian 146 34.9 0.69 0.47–1.02 19.2 6.5 3.7–11.4
Mixed 84 40.5 0.79 0.53–1.18 16.7 4.7 2.3–9.6
Chinese/other 47 21.3 0.28 0.15–0.52 27.7 10.6 4.6–24.3
Notes: Current smokers were compared with current nonsmokers and never smokers were compared with ever smokers using multiple logistic regression, controlling for 
age, sex, deprivation score, and practice clustering. Excludes people with no recording of ethnicity. Bold indicates statistical significance, P,0.05.
Abbreviations: OR, odds ratio; CI, confidence interval.
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OR, 4.9; CI, 3.4–7.1). All ethnic groups were significantly 
more likely to have never smoked than the white group.
access to spirometry
In the whole population, black people were significantly less 
likely to have spirometry performed, whatever the result 
(adjusted OR, 0.64; CI, 0.58–0.70). Among COPD patients, 
black patients were significantly more likely to have had 
spirometry performed than white patients (adjusted OR, 1.55; 
CI, 1.06–2.26). There was no significant ethnic difference in 
the likelihood of COPD being confirmed on spirometry.
Prescribing among COPD patients
There were no significant ethnic differences in the likeli-
hood of being prescribed SABA, SAMA, LABA, ICS, ICS/
LABA, oral steroids, or mucolytics, when controlling for 
age, sex, deprivation, smoking, and COPD severity. LAMAs 
were less likely to be prescribed in black people than white 
people (OR, 0.53; CI, 0.42–0.68; n=1,667). Theophyllines 
were more likely to be prescribed in Asian people (OR, 3.92; 
CI, 1.23–12.5; n=32).
severity of COPD
Black ethnicity was a significant predictor of lower % pre-
dicted FEV
1
 (B coefficient, -7.59; CI, -10.0 to -5.2) com-
pared to white ethnicity, as was Asian ethnicity (B coefficient, 
-4.23; CI, -7.11 to -1.34), when adjusting for age, sex, 
smoking status, IMD score, and practice clustering (n=2,824). 
Results were similar when this analysis was performed on 
patients with spirometry-confirmed COPD only (n=1,509) 
(Table 5). When the severity analysis was repeated using 
ethnic-specific predicted FEV
1
 values rather than raw ECSC 
values, it showed no significant ethnic difference in % 
predicted FEV
1
 for all COPD patients and for spirometry-
confirmed COPD patients (Table 5). Note that some patients 
with a COPD diagnosis had a % predicted FEV
1
 value but 
did not necessarily have spirometry-confirmed COPD (ie, 
FEV
1
/FVC ratio ,0.7).
Discussion
Black people in London were less than half as likely as 
white people to have a diagnosis of COPD when age, sex, 
smoking, deprivation, and practice clustering were taken 
into account (adjusted OR, 0.44; CI, 0.39–0.51). COPD 
drugs were equally likely to be prescribed in each ethnic 
group for similar severities of COPD, but LAMAs were 
less commonly prescribed in black people. Black COPD 
patients were less likely to be current smokers and much 
less likely to have ever smoked. Black ethnicity appeared 
to be a predictor of poorer lung function in COPD patients, 
an effect that disappeared when ethnic-specific predicted 
FEV
1
 values were used.
Diagnosis of COPD was less common in all nonwhite 
ethnic groups compared to white people. On subgroup 
analysis, the white ethnic group was heterogeneous in the 
distribution of COPD prevalence, with the “other white” 
Table 5 Comparison of COPD severity (% predicted FeV1) between ethnic groups among all COPD patients (n=2,824) and spirometry-
confirmed COPD patients (n=1,509)
Ethnic group % predicted FEV1  
(ECSC-derived predicted values)
% predicted FEV1  
(ethnicity-specific predicted values)
B coefficient 95% CI Standardized β B coefficient 95% CI Standardized β
All COPD patients (n=2,824)
White
Black or black British -7.59 -10.0 to -5.2 -0.111 -1.09 -1.6 to 3.8 0.016
asian or asian British -4.23 -7.1 to -1.3 -0.038 0.37 -2.7 to 3.4 0.003
Mixed -4.95 -10.0 to 0.1 0.033 -4.95 -10.1 to 0.1 -0.032
Chinese/other -3.08 -9.7 to 3.5 0.016 -3.10 -9.7 to 3.5 -0.016
Spirometry-confirmed COPD (n=1,509)
White
Black or black British -8.99 -12.00 to -5.97 -0.140 -1.63 -5.02 to 1.76 0.016
asian or asian British -5.12 -10.22 to -0.02 -0.050 -1.14 -6.58 to 4.30 0.003
Mixed -7.48 -15.27 to 0.31 0.050 -7.46 -15.27 to 0.34 -0.032
Chinese/other -2.46 -9.61 to 4.69 0.012 -2.48 -9.63 to 4.67 -0.016
Notes: A sensitivity analysis using ethnicity-specific predicted FEV1 values is included. Multiple linear regression controlling for age, sex, smoking status, deprivation, and 
practice clustering. Excludes people with no recording of ethnicity. Bold indicates statistical significance, P,0.05.
Abbreviations: eCsC, european Coal and steel Community; FeV1, forced expiratory volume in 1 second; CI, confidence interval.
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subgroup significantly less likely to have COPD than the 
white British subgroup. The white Irish subgroup was the 
only subgroup more likely to have COPD than the white 
British subgroup.
strengths and limitations
This study used data from a large population with a high 
proportion of ethnic minority groups. It is the first population 
study to compare ethnic differences in COPD prevalence in 
a population with a large minority of black subjects. Such a 
cross-sectional study can describe relationships, but it cannot 
explain them. As with any routinely collected data, the quality 
of data could not be independently verified. We searched for 
any previous smoking history in never-smokers, to overcome 
the underreporting of ex-smokers that is known to occur in 
primary care records.26 Smoking status and ethnicity were 
more likely to be recorded in patients with COPD. Smoking 
status was also more commonly recorded in white people 
than other ethnic groups. It is possible that lower reporting 
of smoking status in minority ethnic groups had a small 
influence on the adjustment for smoking in the comparison 
of COPD prevalence.
Data were not available on family history of COPD and 
environmental exposures, both of which are associated with 
higher risk of COPD.20,27 Cannabis smoking is not recorded in 
this dataset. Cannabis smoking is associated with respiratory 
symptoms and worse lung function over and above tobacco 
smoking.28 Black Caribbean people are known to be more 
likely, but black African people considerably less likely, than 
white people to smoke cannabis.29 It is unclear how cannabis 
smoking data might affect our results.
We have previously shown that up to 30% of those with 
a diagnosis of COPD in primary care may not have the 
diagnosis confirmed on spirometry.2 We chose to include all 
recorded COPD diagnoses on the assumption that diagnosis 
not confirmed on spirometry would be unlikely to be related 
to ethnic groups. Omitting nonconfirmed cases would risk 
weakening our findings and underestimating prevalence. 
This decision was supported by the sensitivity analysis of 
spirometry-confirmed COPD giving similar results.
Concepts of ethnicity and race are difficult and potentially 
sensitive to define. UK census ethnicity categories, used in 
this study, are heterogeneous and not specific. They may dif-
fer from census ethnic categories in other countries, especially 
with respect to the Asian group. The prevalence of COPD 
varied widely between ethnic groups but also within ethnic 
groups. For example, within the white group, “other white” 
people were less likely to have COPD than white British (OR, 
0.55; CI, 0.46–0.67). Ethnic subgroups include people from 
diverse ethnic, cultural, and racial backgrounds. Nonetheless, 
the narrow confidence intervals of the ORs are likely to rep-
resent true underlying ethnic differences in COPD risk.
COPD appeared more severe in black people, but that 
difference was not maintained when ethnic-specific predicted 
FEV
1
 values were used as recommended by the BTS.18 We 
have already described in the “Introduction” section the 
difficulties in interpreting spirometry data from different 
ethnic groups. Adjustment for ethnicity in predicting normal 
spirometry values is controversial and has been opposed by 
Burney and Hooper17 on the basis of US data showing that 
overall mortality increases with poorer ventilatory function, 
regardless of ethnicity.
While % predicted FEV
1
 is one marker of severity, 
respiratory symptoms in COPD patients affect quality of 
life30 and are likely to affect treatment-seeking behavior. 
Therefore, comparing symptom scores, such as the Medical 
Research Council (MRC) breathlessness score, between 
ethnic groups would be valuable. The MRC score was not 
available for patients in this study.
There was no evidence of ethnic differences in the medi-
cal care of COPD to judge from the distribution of recorded 
spirometry and drug prescribing. The exception to this obser-
vation was the lower rate of prescribing of inhaled antimusca-
rinics in black people. The conduct of multiple drug analyses 
raises the possibility that this was a spurious finding.
Previous research
Our finding of a lower likelihood of COPD in nonwhite 
ethnic groups was similar to that of Martin et al.1 This is the 
first time this observation has been made in a population 
with a large minority of black people. Unlike Martin et al,1 
we were able to detect ethnic differences in severity, and we 
have shown the relevance of ethnic-specific reference values 
for predicted FEV
1
.
Although it is clear that the differences in % predicted 
FEV
1
 between ethnic groups are statistically significant 
when using raw ECSC-derived predicted FEV
1
, the clinical 
significance of these differences is less clear-cut. A minimum 
clinically important difference for absolute FEV
1
 has not been 
definitively established, although it has been estimated at 
around 100 mL,31 or an equivalent 4% change in % predicted 
FEV
1
.32 This would suggest that the observed B coefficient 
values of -7.59 for black patients and -4.23 for Asian patients 
might be clinically significant.
We found lower smoking rates in black people, similar to 
population surveys.33 Like Martin et al,1 we found that black 
International Journal of COPD 2016:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
745
Does COPD risk vary by ethnicity?
and Asian COPD patients were significantly less likely to be 
current smokers than white people. Martin et al1 suggested 
this may be because black and Asian COPD patients are more 
likely to stop smoking. We also found that COPD patients 
of all ethnic groups were significantly more likely to have 
never smoked than white patients. This might support an 
alternative hypothesis that COPD in these groups is more 
likely to be due to risk factors other than smoking. These 
risk factors, for example, tuberculosis infection or biomass 
smoke exposure, might be more common in ethnic immigrant 
groups.27 It is also possible that the COPD phenotype due to 
these exposures is different to the COPD phenotype due to 
smoking.27 Such differences could explain some of the 
differences in severity between ethnic groups.
Interpretation
The reasons for the ethnic differences in COPD prevalence 
observed are likely to be complex. They could be due to broad 
categories of ethnic differences in access to care, ethnic dif-
ferences in normal spirometry, ethnic differences in suscep-
tibility to COPD, or ethnic differences in smoking patterns.
Poorer access to primary care in ethnic minorities might 
lead to later presentation with respiratory symptoms and later 
diagnosis with more severe disease. This could in turn lead 
to a similar pattern of disease to that observed in this study. 
We do not have firm evidence for or against this hypothesis, 
and we do not have access to consultation rates. In support, 
we found higher rates of unknown smoker status in black 
people, which might indicate less detailed recording. We 
found that spirometry was less likely to be performed on 
black people in the general population, but more likely to be 
done on black COPD patients. We found no ethnic differ-
ences in prescribing of seven classes of COPD medications, 
but less prescribing of LAMAs in black COPD patients.
Healthy black people have lower normal FEV
1
 and 
FVC values than white people of a comparable age and 
height.14,16,17 Using standard ECSC reference values would 
result in lower % predicted FEV
1
 for a given FEV
1
 value. 
This could lead to an artifactual impression of more severe 
disease, when in fact the reference values being used were 
inappropriate. This is supported by our sensitivity analysis, 
which found no ethnic difference in severity when ethnic-
specific normal values were used. This is a controversial sub-
ject in COPD epidemiology. Greater clarity and consensus 
is needed on whether spirometry reference equations should 
adjust for ethnicity or not.
We do not have evidence for a biological ethnic difference 
in susceptibility to COPD. There is some evidence from other 
studies of ethnic differences in risk of lung cancer.34 There 
is also evidence of ethnic differences in nicotine absorption, 
metabolism, and addictive potential,35,36 which might affect 
smoking behavior (such as number of cigarettes smoked and 
depth of inhalation) and therefore risk.
Conclusion
Black people in London were half as likely as white people to 
have COPD, even after adjusting for different smoking rates. 
Given the markedly lower smoking rates in black people, it 
seems plausible that there may be other ethnic differences 
in smoking patterns, such as number of cigarettes per day. 
This may account for differences in COPD risk and severity, 
and should be the focus for future research.
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